Skip Navigation



Human Reproduction Update Advance Access published online on June 28, 2006
Human Reproduction Update, doi:10.1093/humupd/dml027
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/5/499    most recent
dml027v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wildschut, H. I.J.
Right arrow Articles by Weiner, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wildschut, H. I.J.
Right arrow Articles by Weiner, C. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received April 10, 2006
Revised May 3, 2006
Accepted May 20, 2006

Article

Screening in women’s health, with emphasis on fetal Down’s syndrome, breast cancer and osteoporosis

Hajo I.J. Wildschut 1 *, T.J. Peters 2, and Carl P. Weiner 3

1 Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, The Netherlands
2 Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, Clifton, Bristol, UK
3 Department of Obstetrics and Gynecology, University of Kansas School of Medicine, Kansas City, KS, USA

* To whom correspondence should be addressed.
Hajo I.J. Wildschut, E-mail: h.wildschut{at}erasmusmc.nl


  Abstract

Screening tests have become increasingly popular in women’s health care over the last two decades. The initiative for screening is typically generated by either an agency or the health care professional being consulted for some reason. In many instances, however, the demand for screening tests is patient driven with the health care provider being poorly prepared to determine the usefulness of screening. This review illustrates the complexity of screening using three disorders where early detection and treatment have the potential to improve the quality and longevity of life. Prenatal diagnosis of Down’s syndrome does not offer the parents the opportunity for cure but does offer the opportunity for education and rational choice as the impact of the diagnosis on the family is weighed. The evidence for breast cancer screening is more persuasive for older than younger women, but even in older women, there is a balance of risks and benefits. Treatment options for osteoporosis have improved in terms of reductions in fracture risk as well as beneficial effects on bone density, but evidence of the effectiveness of a screening programme for this condition in an unselected population is lacking. Ultimately, it is crucial that women be provided with clear and comprehensive information about the screening programme, in terms of possible gains but also costs of various kinds: physical, economic and psychological.

Keywords: breast cancer/Down’s syndrome/informed choice/osteoporosis/screening.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
M.A. Durand, J. Boivin, and G. Elwyn
A review of decision support technologies for amniocentesis
Hum. Reprod. Update, September 4, 2008; (2008) dmn037v1.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.